Dudediligence.

EyePoint, Inc

EYPTNASDAQ · Laboratory Analytical Instruments
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$10.5MSep ’24$11.6MDec ’24$24.5MMar ’25$5.3MJun ’25$966,000Sep ’25$620,000Dec ’25$696,000Mar ’26$507,000Jun ’26
Net income, by quarter
−$29.4MSep ’24−$41.4MDec ’24−$45.2MMar ’25−$59.4MJun ’25−$59.7MSep ’25−$67.6MDec ’25−$84.8MMar ’26−$94.5MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025Jun 2026
Revenue$41.4M$46.0M$43.3M$31.4Mnone on file
Operating income−$99.6M−$75.1M−$145.9M−$243.4Mnone on file
Net income−$102.3M−$70.8M−$130.9M−$232.0Mnone on file
Operating cash flow−$65.0M$1.9M−$126.2M−$240.1Mnone on file
Free cash flow−$67.2M−$1.6M−$130.3M−$243.4Mnone on file
Cash$95.6M$281.3M$99.7M$101.8M$110.5M
Debt$39.8M$0.00none on filenone on filenone on file
Shares outstanding34.1M49.0M68.3M82.8M85.0M